510(k) K970985
K970985 is an FDA 510(k) premarket notification submitted by Wako Chemicals USA, Inc. for the device "WAKO TOTAL BILIRUBIN V". The FDA issued a decision of Substantially Equivalent on April 21, 1997. The device falls under product code JFM (Enzymatic Method, Bilirubin), a Class II device regulated under 21 CFR 862.1110. Wako Chemicals USA, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 21, 1997
- Date Received
- March 18, 1997
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzymatic Method, Bilirubin
- Device Class
- Class II
- Regulation Number
- 862.1110
- Review Panel
- CH
- Submission Type